Comparative effect of saxagliptin and glimepiride with a composite endpoint of adequate glycaemic control without hypoglycaemia and without weight gain in patients uncontrolled with metformin therapy: Results from the SPECIFY study, a 48-week, multi-centr

Gu, TW; Ma, JH; Zhang, Q; Zhu, LY; Zhang, H; Xu, L; Cheng, JL; Shi, BM; Li, DM; Shao, JQ; Sun, ZL; Zhong, S; Bi, Y; Zhu, DL

Bi, Y; Zhu, DL (reprint author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Endocrinol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.

DIABETES OBESITY & METABOLISM, 2019; 21 (4): 939

Abstract

Aims To compare the efficacy and safety of saxagliptin and glimepiride in type 2 diabetes (T2D) patients who are inadequately controlled with metformi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索